Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T20:33:04.861Z.
Calculation as of: 2026-10-06T20:33:04.861Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d1c9d1ae32ec6dd6af333f7eb1423604a85a264941186084cc2bd56372a90b7e
PEG RATIO
N/A
Sensus Healthcare, Inc.
Market Cap
$48.89M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | $48.89M | N/A |
| TELA Bio, Inc. (TELA)vs › | $48.77M | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A |
| Apollomics, Inc. (APLM)vs › | $48.53M | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | N/A |
| Clene Inc. (CLNN)vs › | $49.45M | N/A |
| INmune Bio, Inc. (INMB)vs › | $49.71M | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | N/A |
| biote Corp. (BTMD)vs › | $50.28M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
